Pediatrix Medical Group, Inc. P/E Ratio 2008–2025
Pediatrix Medical Group, Inc. reported 11.03 of price-to-earnings ratio for fiscal 2025. That was 41.4% lower than fiscal 2022. Compared with fiscal 2018, the change was -2.1%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 11.03 | — |
| FY 2024 | — | — |
| FY 2023 | — | — |
| FY 2022 | 18.81 | +5.8% |
| FY 2021 | 17.78 | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | 11.26 | -27.3% |
| FY 2017 | 15.49 | -18.9% |
| FY 2016 | 19.10 | -4.6% |
| FY 2015 | 20.02 | -3.7% |
| FY 2014 | 20.79 | +8.3% |
| FY 2013 | 19.20 | +16.9% |
| FY 2012 | 16.43 | +1.8% |
| FY 2011 | 16.15 | +2.2% |
| FY 2010 | 15.80 | -0.7% |
| FY 2009 | 15.90 | +80.1% |
| FY 2008 | 8.83 | — |
Source: Pediatrix Medical Group, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Pediatrix Medical Group, Inc. reported 11.03 of price-to-earnings ratio for fiscal 2025. That was 41.4% lower than fiscal 2022. Compared with fiscal 2018, the change was -2.1%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Pediatrix Medical Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePediatrix Medical Group, Inc. — frequently asked questions
What is Pediatrix Medical Group, Inc.'s price-to-earnings ratio?
Pediatrix Medical Group, Inc. (MD) reported price-to-earnings ratio of 11.03 for fiscal year 2025, per its SEC filings.
How has Pediatrix Medical Group, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, MD's price-to-earnings ratio grew at roughly 1.3% per year (compound annual rate), from 8.83 to 11.03.
Where does this data come from?
Figures are computed from Pediatrix Medical Group, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More MD financial history
Full MD fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →